Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
Mosaicism for GJB1 mutation causes milder Charcot-Marie-Tooth X1 phenotype in a heterozygous man than in a manifesting heterozygous woman.
Assessing humoral immunocompetence after alemtuzumab treatment in MS.
[Multiple sclerosis and physical activity : An historical perspective.]
Chronic inflammatory demyelinating polyneuropathy with papillodema and response to immunoglobulins.
The interplay between bacillus Calmette-Guérin and Treg cells and its role to prevent or cure inflammatory diseases.
Mesenchymal cells of umbilical cord and umbilical cord blood as a source of human oligodendrocyte progenitors.
Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
Neurodegeneration in multiple sclerosis is a process separate from inflammation: No.
Involvement of membrane skeletal molecules in the Schmidt-Lanterman incisure in Schwann cells.
Over the past decade, we have made great advances in the field of multiple sclerosis. Introduction.
Autologous mesenchymal stem cells applied on the pressure ulcers had produced a surprising outcome in a severe case of neuromyelitis optica.
Predictors of exercise participation in ambulatory and non-ambulatory older people with multiple sclerosis.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland.
Ranking of Disease-Modifying Therapies for Multiple Sclerosis.
Adult oligodendrocyte progenitor cells - Multifaceted regulators of the CNS in health and disease.
The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
Syndrome of inappropriate antidiuretic hormone secretion in patients with aquaporin-4 antibody.
Engagement in a program promoting lifestyle modification is associated with better patient-reported outcomes for people with MS.
Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype.
IVIg for relapsing-remitting multiple sclerosis: promises and uncertainties.
Lesser-known myelin-related disorders: Focal tumour-like demyelinating lesions.
An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy.
Neuromyelitis Optica IgG Causes Placental Inflammation and Fetal Death.
Evaluation of Rho-Kinase Activity in Mice Brain Using N-[(11)C]Methyl-hydroxyfasudil with Positron Emission Tomography.
Pages
« first
‹ previous
…
639
640
641
642
643
644
645
646
647
…
next ›
last »